Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

  • Juárez Fernández, María
  • Goikoetxea Usandizaga, Naroa
  • Porras Sanabria, David
  • García Mediavilla, María Victoria
  • Bravo, Miren
  • Serrano Maciá, Marina
  • Simón, Jorge
  • Delgado, Teresa C.
  • Lachiondo Ortega, Sofía
  • Martínez Flórez, Susana
  • Lorenzo, Óscar
  • Rincón, Mercedes
  • Varela Rey, Marta
  • Abecia, Leticia
  • Rodríguez, Héctor
  • Anguita, Juan
  • Nistal González, Maria Esther
  • Martínez Chantar, María Luz
  • Sánchez Campos, Sonia
[EN] Background and Aims: Recent studies suggest that mitochondrial dysfunction promotes progression to NASH by aggravating the gut-liver status. However, the underlying mechanism remains unclear. Herein, we hypothesized that enhanced mitochondrial activity might reshape a specific microbiota signature that, when transferred to germ-free (GF) mice, could delay NASH progression. Approach and Results: Wild-type and methylation-controlled J protein knockout (MCJ-KO) mice were fed for 6 weeks with either control or a choline-deficient, L-amino acid–defined, high-fat diet (CDA-HFD). One mouse of each group acted as a donor of cecal microbiota to GF mice, who also underwent the CDA-HFD model for 3 weeks. Hepatic injury, intestinal barrier, gut microbiome, and the associated fecal metabolome were then studied. Following 6 weeks of CDA-HFD, the absence of methylation-controlled J protein, an inhibitor of mitochondrial complex I activity, reduced hepatic injury and improved gut-liver axis in an aggressive NASH dietary model. This effect was transferred to GF mice through cecal microbiota transplantation. We suggest that the specific microbiota profile of MCJ-KO, characterized by an increase in the fecal relative abundance of Dorea and Oscillospira genera and a reduction in AF12, Allboaculum, and [Ruminococcus], exerted protective actions through enhancing short-chain fatty acids, nicotinamide adenine dinucleotide (NAD+) metabolism, and sirtuin activity, subsequently increasing fatty acid oxidation in GF mice. Importantly, we identified Dorea genus as one of the main modulators of this microbiota-dependent protective phenotype. Conclusions: Overall, we provide evidence for the relevance of mitochondria–microbiota interplay during NASH and that targeting it could be a valuable therapeutic approach., SI, Publicación en abierto financiada por el Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE), con cargo al Programa Operativo 2014ES16RFOP009 FEDER 2014-2020 DE CASTILLA Y LEÓN, Actuación:20007-CL - Apoyo Consorcio BUCLE
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Tesis doctoral (DoctoralThesis)

Gut microbiota modulation as an alternative in the management of non-alcoholic fatty liver disease and obesity, Modulación de la microbiota intestinal como alternativa terapéutica en el manejo de la enfermedad de hígado graso no alcohólico y la obesidad

  • Juárez Fernández, María
155 p., [EN] Nowadays, obesity and NAFLD are two of the most important public health concerns worldwide. The lack of an effective treatment to face them, along with the current sedentary lifestyle and the intake of high-fat and high-sugar diets have led to an increasing trend in the prevalence of both diseases, with shocking future estimations. In the last years, gut microbiota has been identified as a key contributor factor to the development of these diseases, so it has become a research field not only in the characterization of the pathogenic mechanisms, but also in the hunt for new therapeutic alternatives. In this sense, the modulation of gut microbiota through different strategies such as fecal microbiota transplantation or the administration of probiotics, prebiotics, and synbiotics are being considered as possible treatments to face both obesity and NAFLD. In the present PhD Thesis, the general aim is to identify the role of the gut microbiota in the pathogenesis of these two diseases, as well as to explore the therapeutic potential of gut microbiota modulation., Ministerio de Economía y Competitividad. Secretaría de Estado de Investigación, Junta de Castilla y León, Junta de Castilla y León. Consejería de Sanidad. Gerencia Regional de Salud de Castilla y León
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children

  • Quiroga, Rocío
  • Nistal González, Maria Esther
  • Estébanez González, Brisamar
  • Juárez Fernández, María
  • Martínez Flórez, Susana
  • García Mediavilla, María Victoria
  • Paz Fernández, José Antonio de
  • González Gallego, Javier
  • Sánchez Campos, Sonia
  • Cuevas González, María José
  • Porras Sanabria, David
[EN] Childhood obesity has reached epidemic levels and is a serious health concern associated with metabolic syndrome, nonalcoholic fatty liver disease, and gut microbiota alterations. Physical exercise is known to counteract obesity progression and modulate the gut microbiota composition. This study aims to determine the effect of a 12-week strength and endurance combined training program on gut microbiota and inflammation in obese pediatric patients. Thirty-nine obese children were assigned randomly to the control or training group. Anthropometric and biochemical parameters, muscular strength, and inflammatory signaling pathways in mononuclear cells were evaluated. Bacterial composition and functionality were determined by massive sequencing and metabolomic analysis. Exercise reduced plasma glucose levels and increased dynamic strength in the upper and lower extremities compared with the obese control group. Metagenomic analysis revealed a bacterial composition associated with obesity, showing changes at the phylum, class, and genus levels. Exercise counteracted this profile, significantly reducing the Proteobacteria phylum and Gammaproteobacteria class. Moreover, physical activity tended to increase some genera, such as Blautia, Dialister, and Roseburia, leading to a microbiota profile similar to that of healthy children. Metabolomic analysis revealed changes in short-chain fatty acids, branched-chain amino acids, and several sugars in response to exercise, in correlation with a specific microbiota profile. Finally, the training protocol significantly inhibited the activation of the obesity-associated NLRP3 signaling pathway. Our data suggest the existence of an obesity-related deleterious microbiota profile that is positively modified by physical activity intervention. Exercise training could be considered an efficient nonpharmacological therapy, reducing inflammatory signaling pathways induced by obesity in children via microbiota modulation., This work was supported by grants from Ministerio de Economía, Industria y Competitividad (BFU2017–87960-R), Junta de Castilla y León and the European Regional Development Fund (FEDER) (LE063U16 and GRS1888/A/18). CIBERehd is funded by the Instituto de Salud Carlos III, Spain. B.E and M.J.F were supported by a fellowship from Ministerio de Educación (FPU15/05051 and FPU18/06257). E.N. was supported by Fundación de Investigación Sanitaria of León. D.P. was supported by a fellowship from Junta de Castilla y León, cofinanced by the European Social Fund.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease

  • Porras Sanabria, David
  • Nistal González, Maria Esther
  • Martínez Flórez, Susana
  • González Gallego, Javier
  • García Mediavilla, María Victoria
  • Sánchez Campos, Sonia
[EN] Obesity and associated comorbidities, including non-alcoholic fatty liver disease (NAFLD), are a major concern to public well-being worldwide due to their high prevalence among the population, and its tendency on the rise point to as important threats in the future. Therapeutic approaches for obesity-associated disorders have been circumscribed to lifestyle modifications and pharmacological therapies have demonstrated limited efficacy. Over the last few years, different studies have shown a significant role of intestinal microbiota (IM) on obesity establishment and NAFLD development. Therefore, modulation of IM emerges as a promising therapeutic strategy for obesity-associated diseases. Administration of prebiotic and probiotic compounds, fecal microbiota transplantation (FMT) and exercise protocols have shown a modulatory action over the IM. In this review we provide an overview of current approaches targeting IM which have shown their capacity to counteract NAFLD and metabolic syndrome features in human patients and animal models., SI, This work was supported by grants to JG-G and SS-C from Ministerio de Economía y Competitividad/FEDER (BFU2017- 87960-R) and Junta de Castilla y León (LE063U16 and GRS 1888/A/18). DP was supported by a fellowship from Junta de Castilla y León co-financed by the European Social Fund. EN was supported by Fundación de Investigación Sanitaria of León. MG-M was supported by CIBERehd contracts. CIBERehd is funded by the Instituto de Salud Carlos III, Spain.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver axis crosstalk in an "in vivo" model of early obesity and non-alcoholic fatty liver disease

  • Carbajo Pescador, Sara
  • Porras Sanabria, David
  • García Mediavilla, María Victoria
  • Martínez Flórez, Susana
  • Juárez Fernández, María
  • Cuevas González, María José
  • Mauriz Gutiérrez, José Luis
  • González Gallego, Javier
  • Nistal González, Maria Esther
  • Sánchez Campos, Sonia
[EN]Childhood obesity has reached epidemic levels, representing one of the most serious public health concerns associated with metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). There is limited clinical experience concerning pediatric NAFLD patients, and thus the therapeutic options are scarce. The aim of this study was to evaluate the benefits of exercise on gut microbiota composition and functionality balance, and consequent effects on early obesity and NAFLD onset in an in vivo model. Juvenile (21-day-old) male Wistar rats fed a control diet or a high-fat diet (HFD) were subjected to a combined aerobic and resistance training protocol. Fecal microbiota was sequenced by an Illumina MiSeq system, and parameters related to metabolic syndrome, fecal metabolome, intestinal barrier integrity, bile acid metabolism and transport, and alteration of the gut-liver axis were measured. Exercise decreased HFD-induced body weight gain, metabolic syndrome and hepatic steatosis, as a result of its lipid metabolism modulatory capacity. Gut microbiota composition and functionality were substantially modified as a consequence of diet, age and exercise intervention. In addition, the training protocol increased Parabacteroides, Bacteroides and Flavobacterium genera, correlating with a beneficial metabolomic profile, whereas Blautia, Dysgonomonas and Porphyromonas showed an opposite pattern. Exercise effectively counteracted HFD-induced microbial imbalance, leading to intestinal barrier preservation, which, in turn, prevented deregulation of the gut-liver axis and improved bile acid homeostasis, determining the clinical outcomes of NAFLD. In conclusion, we provide scientific evidence highlighting the benefits of gut microbiota composition and functionality modulation by physical exercise protocols in the management of early obesity and NAFLD development., SI, This work was supported by grants from Ministerio de Economıa y Competitividad ́ (BFU2017-87960-R), Junta de Castilla y León and the European Regional Development Fund (FEDER) (LE063U16 and GRS1888/A/18). D.P. and S.C.-P. were supported by a fellowship from Junta de Castilla y León, co-financed by the European Social Fund. E.N. was supported by Fundación de Investigación Sanitaria of León. M.V.G.-M. was supported by contracts from the CIBERehd, which is funded by Instituto de Salud Carlos III.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation

  • Juárez Fernández, María
  • Porras Sanabria, David
  • Petrov, Petar
  • Román Sagüillo, Sara
  • García Mediavilla, María Victoria
  • Soluyanova, Polina
  • Martínez Flórez, Susana
  • González Gallego, Javier
  • Nistal González, Maria Esther
  • Jover Atienza, Ramiro
  • Sánchez Campos, Sonia
[EN] Gut microbiota plays a key role in obesity and non-alcoholic fatty liver disease (NAFLD), so synbiotics could be a therapeutic alternative. We aim to evaluate a nutritional intervention together with the administration of the bacteria Akkermansia muciniphila and the antioxidant quercetin in an in vivo model of early obesity and NAFLD. 21-day-old rats were fed with control or high-fat diet for six weeks. Then, all animals received control diet supplemented with/without quercetin and/or A. muciniphila for three weeks. Gut microbiota, NAFLD-related parameters, circulating bile acids (BAs) and liver gene expression were analyzed. The colonization with A. muciniphila was associated with less body fat, while synbiotic treatment caused a steatosis remission, linked to hepatic lipogenesis modulation. The synbiotic promoted higher abundance of Cyanobacteria and Oscillospira, and lower levels of Actinobacteria, Lactococcus, Lactobacillus and Roseburia. Moreover, it favored elevated unconjugated hydrophilic BAs plasma levels and enhanced hepatic expression of BA synthesis and transport genes. A. muciniphila correlated with circulating BAs and liver lipid and BA metabolism genes, suggesting a role of this bacterium in BA signaling. Beneficial effects of A. muciniphila and quercetin combination are driven by gut microbiota modulation, the shift in BAs and the gut-liver bile flow enhancement., SI, This work was supported by grants from Ministerio de Economía y Competitividad/FEDER (BFU2017-87960-R; PID2020-120363RB-I0), Junta de Castilla y León (FEDER) (GRS2126/A/2020; LE063U16; LE017P20), and Instituto de Salud Carlos III (PI17/01089, PI20/00690, cofunded by European Regional Development Fund “A way to achieve Europe”). MJF was supported by a fellowship from Ministerio de Ciencia, Innovación y Universidades (FPU18/06257); DP and SRS by a fellow-ship from Junta de Castilla y León cofunded by the European Social Fund; PP by Sara Borrell Postdoctoral Contract CD18/00158 from the Instituto de Salud Carlos III, cofunded by the European Social Fundation. CIBERehd is funded by the Instituto de Salud Carlos III, Spain.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non‐Alcoholic Fatty Liver Disease

  • Petrov, Petar Dianov
  • García Mediavilla, María Victoria
  • Guzmán, Carla
  • Porras Sanabria, David
  • Nistal González, Maria Esther
  • Martínez Flórez, Susana
  • Castell, José Vicente
  • González Gallego, Javier
  • Sánchez Campos, Sonia
  • Jover Atienza, Ramiro
[EN] Scope: Gut microbiota contributes to non-alcoholic fatty liver disease (NAFLD) pathogenesis by multiple mechanisms not yet completely understood. Novel differential features between germ-free mice (GFm) transplanted with protective or non-protective cecal microbiota against NAFLD are investigated. Methods and results: Gut microbiota composition, plasma, and fecal bile acids (BAs) and liver mRNAs are quantified in GFm recipients from four donor mice differing in NAFLD severity (control diet, high-fat diet [HFD]-responder, HFD-non-responder, and quercetin-supplemented HFD). Transplanted GFm are on control or HFD for 16-weeks. Multivariate analysis shows that GFm colonized with microbiota from HFD-non-responder and quercetin supplemented-HFD donors (protected against NAFLD) clusters together, whereas GFm colonized with microbiota from control and HFD-responder mice (non-protected against NAFLD) establishes another cluster. Protected phenotype is associated with increased gut Desulfovibrio and Oscillospira, reduced gut Bacteroides and Oribacterium, lower primary and higher secondary BAs in plasma and feces, induction of hepatic BA transporters, and repression of hepatic lipogenic and BA synthesis genes. Conclusion: Protective gut microbiota associates with increased specific secondary BAs, which likely inhibit lipogenic pathways and enhance bile flow in the liver. This novel cross-talk between gut and liver, via plasma BAs, that promotes protection against NAFLD may have clinical and nutritional relevance, SI, P.D.P. and M.V.G.-M. share first authorship. S.S.-C. and R.J. share se-nior authorship. The authors thank Drs. G ́erard and Rabot, from MI-CALIS Institute (INRA), for providing germ-free mice. The authors wouldalso like to thank the Analytical Unit of Instituto de Investigaci ́on San-itaria La Fe, Valencia, for performing the bile acid profiling in plasmaand feces. This study has been funded by Instituto de Salud Carlos IIIthrough the project “PI17/01089” (cofounded by European Regional De-velopment Fund “A way to achieve Europe”) and by grants from Minis-terio de Econom ́ıa y Competitividad/Fondo Europeo de Desarrollo Re-gional (FEDER) (BFU2013-48141-R and BFU2017-87960-R) and Junta deCastilla y Le ́on/FEDER (LE063U16 and GRS1888/A/18). P.D.P. was sup-ported by Sara Borrell Postdoctoral Contract CD18/00158 from the Insti-tuto de Salud Carlos III, cofounded by the European Social Fund. D.P.was supported by a fellowship from Junta de Castilla y Le ́on cofinancedby the European Social Fund. E.N. was supported by Fundaci ́on de Inves-tigaci ́on Sanitaria of Le ́on. M.V.G.-M. was supported by CIBERehd con-tracts. CIBERehd is funded by the Instituto de Salud Carlos III, Spain
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High‐Fat Diet Determine Non‐Alcoholic Fatty Liver Disease Development in Germ‐Free Mice

  • Porras Sanabria, David
  • Nistal González, Maria Esther
  • Martínez Flórez, Susana
  • Olcoz Goñi, José Luis
  • Jover Atienza, Ramiro
  • Jorquera, F.
  • González Gallego, Javier
  • García Mediavilla, María Victoria
  • Sánchez Campos, Sonia
[EN] Scope: Modulation of intestinal microbiota has emerged as a new therapeutic approach for non-alcoholic fatty liver disease (NAFLD). Herein, it is addressed whether gut microbiota modulation by quercetin and intestinal microbiota transplantation can influence NAFLD development. Methods and results: Gut microbiota donor mice are selected according to their response to high-fat diet (HFD) and quercetin in terms of obesity and NAFLD-related biomarkers. Germ-free recipients displayed metabolic phenotypic differences derived from interactions between microbiota transplanted, diets, and quercetin. Based on the evaluation of hallmark characteristics of NAFLD, it is found that gut microbiota transplantation from the HFD-non-responder donor and the HFD-fed donor with the highest response to quercetin results in a protective phenotype against HFD-induced NAFLD, in a mechanism that involves gut–liver axis alteration blockage in these receivers. Gut microbiota from the HFD-responder donor predisposed transplanted germ-free mice to NAFLD. Divergent protective and deleterious metabolic phenotypes exhibited are related to definite microbial profiles in recipients, highlighting the predominant role of Akkermansia genus in the protection from obesity-associated NAFLD development. Conclusions: The results provide scientific support for the prebiotic capacity of quercetin and the transfer of established metabolic profiles through gut microbiota transplantation as a protective strategy against the development of obesity-related NAFLD, SI, M.V.G.M. and S.S.C. share senior authorship. D.P. and E.N. made equal contribution to the study. D.P., E.N., S.M.F., M.V.G.M., and S.S.C. performed most of the experiments. J.L.O. and F.J. performed statistical analysis. R.J. and J.G.G. assisted for in vivo models. S.S.C. designed the experiments and supervised the study. All the authors wrote the manuscript. The authors thank Drs. Gérard and Rabot, from MICALIS Institute (INRA), for providing germ-free mice. This work was supported by grants from Ministerio de Economía y Competitividad and Fondo Europeo de Desarrollo Regional (FEDER) (BFU2013-48141-R, BFU2017-87960-R), Junta de Castilla y León (LE135U13, GRS 1428/A/16), Junta de Castilla y León and FEDER, (LE063U16), and IIS Hospital La Fe (2017_0092_PP). D.P. was supported by a fellowship from Junta de Castilla y León co-financed by the European Social Fund. E.N. was supported by Fundación de Investigación Sanitaria of León. M.V.G.M. was supported by CIBERehd contracts. CIBERehd is funded by the Instituto de Salud Carlos III, Spain
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Long-Term Effects of Bariatric Surgery on Gut Microbiota Composition and Faecal Metabolome Related to Obesity Remission

  • Juárez Fernández, María
  • Román Sagüillo, Sara
  • Porras Sanabria, David
  • García Mediavilla, María Victoria
  • Linares, Pedro
  • Ballesteros Pomar, María Dolores
  • Urioste Fondo, Ana
  • Álvarez Cuenllas, Begoña Carmen
  • González Gallego, Javier
  • Sánchez Campos, Sonia
  • Jorquera Plaza, Francisco
  • Nistal González, Maria Esther
[EN] Obesity is one of the main worldwide public health concerns whose clinical management demands new therapeutic approaches. Bariatric surgery is the most efficient treatment when other therapies have previously failed. Due to the role of gut microbiota in obesity development, the knowledge of the link between bariatric surgery and gut microbiota could elucidate new mechanis-tic approaches. This study aims to evaluate the long-term effects of bariatric surgery in the faecal metagenome and metabolome of patients with severe obesity. Faecal and blood samples were collected before and four years after the intervention from patients with severe obesity. Biochemical, metagenomic and metabolomic analyses were performed and faecal short-chain fatty acids were measured. Bariatric surgery improved the obesity-related status of patients and significantly re-shaped gut microbiota composition. Moreover, this procedure was associated with a specific metab-olome profile characterized by a reduction in energetic and amino acid metabolism. Acetate, butyr-ate and propionate showed a significant reduction with bariatric surgery. Finally, correlation analysis suggested the existence of a long-term compositional and functional gut microbiota profile associated with the intervention. In conclusion, bariatric surgery triggered long-lasting effects on gut microbiota composition and faecal metabolome that could be associated with the remission of obesity, SI, This research was funded by grants from Ministerio de Economía y Competitividad/FEDER (BFU2017-87960-R) and Junta de Castilla y León (GRS1888/A/18)
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Aging, Gut Microbiota and Metabolic Diseases: Management through Physical Exercise and Nutritional Interventions

  • Juárez Fernández, María
  • Porras Sanabria, David
  • García Mediavilla, María Victoria
  • Román Sagüillo, Sara
  • González Gallego, Javier
  • Nistal González, Maria Esther
  • Sánchez Campos, Sonia
[EN] Gut microbiota (GM) is involved in the maintenance of physiological homeostasis, thus the alteration of its composition and functionality has been associated with many pathologies such as metabolic diseases, and could also be linked with the progressive degenerative process in aging. Nowadays, life expectancy is continuously rising, so the number of elder people and the consequent related pathologies demand new strategies to achieve healthy aging. Besides, actual lifestyle patterns make metabolic diseases a global epidemic with increasing trends, responsible for a large mortality and morbidity in adulthood and also compromising the health status of later stages of life. Metabolic diseases and aging share a profile of low-grade inflammation and innate immunity acti-vation, which may have disturbances of GM composition as the leading mechanism. Thus, GM emerges as a therapeutic target with a double impact in the elderly, counteracting both aging itself and the frequent metabolic diseases in this population. This review summarizes the role and com-positional changes of the GM in aging and its modulation through nutritional interventions and physical exercise as a strategy to counteract the aging process and the related metabolic diseases, SI, This work was supported by grants to J.G.-G. and S.S.-C. from Ministerio de Economía y Competitividad/FEDER (BFU2017-87960-R) and Junta de Castilla y León (GRS 1888/A/18). M.J.-F. was supported by a fellowship from Ministerio de Ciencia, Innovación y Universidades (FPU18/06257). D.P. and S.R.-S. were supported by a fellowship from Junta de Castilla y León co-financed by the European Social Fund. E.N. was supported by CIBERehd contracts. CIBERehd is funded by the Instituto de Salud Carlos III, Spain
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity

  • Nistal, Esther
  • Sáenz de Miera, Luis E.
  • Ballesteros Pomar, María
  • Sánchez-Campos, Sonia
  • García-Mediavilla, María Victoria
  • Álvarez-Cuenllas, Begoña
  • Linares, Pedro
  • Olcoz, José Luis
  • Arias-Loste, María Teresa
  • García-Lobo, Juan M.
  • Crespo, Javier
  • González-Gallego, Javier
  • Jorquera Plaza, Francisco
[Introduction]: increasing evidence suggests a role of intestinal dysbiosis in obesity and non-alcoholic fatty liver disease (NAFLD). The advances in recent years with regard to the role of the gut microbiota raise the potential utility of new therapeutic approaches based on the modification of the microbiome., [Objective]: the aim of this study was to compare the bacterial communities in obese patients with or without NAFLD to those of healthy controls. Patients and methods: the fecal microbiota composition of 20 healthy adults, 36 obese patients with NAFLD and 17 obese patients without NAFLD was determined by 16S ribosomal RNA sequencing using the Illumina MiSeq system., [Results]: the results highlighted significant differences in the phylum Firmicutes between patients with and without NAFLD, which was a determining factor of the disease and supported its possible role as a marker of NAFLD. At the genus level, the relative abundance of Blautia, Alkaliphilus, Flavobacterium and Akkermansia was reduced in obese patients, both with or without NAFLD, compared to healthy controls. Furthermore, the number of sequences from the genus Streptococcus was significantly higher in patients with NAFLD in comparison with individuals without the disease, constituting another possible marker. Comparison of bacterial communities at the genus level by a principal coordinate analysis indicated that the bacterial communities of patients with NAFLD were dispersed and did not form a group., [Conclusion]: in conclusion, these results indicate the role of intestinal dysbiosis in the development of NAFLD associated with obesity. There was a differential microbiota profile between obese patients, with and without NAFLD. Thus, supporting gut microbiota modulation as a therapeutic alternative for the prevention and treatment of NAFLD., This work was supported by grants to JGG, SSC and FJ from Ministerio de Economía y Competitividad/FEDER (BFU2013-48141-R and BFU2017-87960-R), Junta de Castilla y León (BIO/LE02/15) and Gerencia Regional de Salud de Castilla y León (GRS1428/A/16 and GRS1888/A/18). MVGM was supported by CIBERehd contracts. CIBERehd is funded by the Instituto de Salud Carlos III, Spain. EN was supported by Fundación de Investigación Sanitaria of León., Peer reviewed